Literature DB >> 8041547

Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes.

F Petraglia1, A Gallinelli, D De Vita, K Lewis, L Mathews, W Vale.   

Abstract

OBJECTIVE: To evaluate maternal serum activin A levels in pregnant women at parturition, correlated to the mode of delivery, and to localize activin receptor messenger RNA in human placenta and fetal membranes.
METHODS: A specific two-site enzyme-linked immunosorbent assay (ELISA) was used to measure maternal activin A levels. Activin receptor mRNA was localized in placenta and fetal membranes by in situ hybridization, using ActRII or ActRIIB antisense riboprobes.
RESULTS: Serum activin A levels increased significantly in pregnant women during vaginal or cesarean delivery after spontaneous labor. No significant changes of serum activin A were found in patients undergoing elective cesarean delivery. Syncytiotrophoblast and amnion cells hybridized to radiolabeled ActRIIB probe, whereas few cells within the structure of the villi and decidual cells hybridized to radiolabeled ActRII probe.
CONCLUSION: The present studies indicate that vaginal or cesarean delivery following spontaneous labor is characterized by increased activin A levels and that activin receptors are present on trophoblast and fetal membranes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041547

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy.

Authors:  L Funghi; M Torricelli; R Novembri; S Vannuccini; G Cevenini; M Di Tommaso; F M Severi; F Petraglia
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

Review 2.  Maternal programming: Application of a developmental psychopathology perspective.

Authors:  Laura M Glynn; Mariann A Howland; Molly Fox
Journal:  Dev Psychopathol       Date:  2018-08

3.  Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy.

Authors:  P Florio; S Luisi; E Casarosa; A R Genazzani; P Pautier; C Lhommé; J M Bidart; P G Driul; F Petraglia
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

4.  Activin-A in myometrium: characterization of the actions on myometrial cells.

Authors:  Pasquapina Ciarmela; Ezra Wiater; Wylie Vale
Journal:  Endocrinology       Date:  2008-01-31       Impact factor: 4.736

5.  Activin-A up-regulates type I activin receptor mRNA levels in human immortalized extravillous trophoblast cells.

Authors:  Victor T S Chen; Chun Peng; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2003-03-24       Impact factor: 5.211

6.  Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

Authors:  Aparna Reddy; Sangeeta Suri; Ian L Sargent; Christopher W G Redman; Shanthi Muttukrishna
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

7.  Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion.

Authors:  Alexandros Daponte; Efthimios Deligeoroglou; Antonios Garas; Spyros Pournaras; Christos Hadjichristodoulou; Ioannis E Messinis
Journal:  Dis Markers       Date:  2013-10-07       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.